Myeloma Patients Europe
@myelomaeurope.bsky.social
A network of highly efficient, effective and sustainable myeloma and AL amyloidosis patient organisations across Europe
CAMMA 3 trial results are out! Watch this video with Dr. Phoebe Joy Ho from the Royal Prince Alfred Hospital and the University of Sydney, Australia, who has just presented this study at #ASH25.
youtu.be/H6EtYJ9xJ7g
youtu.be/H6EtYJ9xJ7g
ASH 2025 | CAMMA 3 clinical trial
YouTube video by Myeloma Patients Europe
youtu.be
December 7, 2025 at 10:34 PM
CAMMA 3 trial results are out! Watch this video with Dr. Phoebe Joy Ho from the Royal Prince Alfred Hospital and the University of Sydney, Australia, who has just presented this study at #ASH25.
youtu.be/H6EtYJ9xJ7g
youtu.be/H6EtYJ9xJ7g
If you want to know more about the #myeloma updates presented at #ASH2025, don't miss our post-ASH webinar, on Wednesday 17 December. Register now!👇
www.mpeurope.org/mpe-webinar-...
@ash.hematology.org @emnmyeloma.bsky.social @europeancancer.bsky.social @eortc.org
www.mpeurope.org/mpe-webinar-...
@ash.hematology.org @emnmyeloma.bsky.social @europeancancer.bsky.social @eortc.org
December 6, 2025 at 2:43 PM
If you want to know more about the #myeloma updates presented at #ASH2025, don't miss our post-ASH webinar, on Wednesday 17 December. Register now!👇
www.mpeurope.org/mpe-webinar-...
@ash.hematology.org @emnmyeloma.bsky.social @europeancancer.bsky.social @eortc.org
www.mpeurope.org/mpe-webinar-...
@ash.hematology.org @emnmyeloma.bsky.social @europeancancer.bsky.social @eortc.org
Katie Joyner, co-CEO of MPE, is highlighting how this programme provides psychological, legal and social support through a multidisciplinary care model.
December 5, 2025 at 2:22 PM
Katie Joyner, co-CEO of MPE, is highlighting how this programme provides psychological, legal and social support through a multidisciplinary care model.